PURCHASE ORDER
Active75F40126P00203
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$574.8K
obligated · signed 3 weeks ago
"EO 14398" FIVE (5) GENOMIC SEQUENCING SYSTEMS MISEQ I100 PLUS SYSTEMS
Performance timeline
Start
Sep 17, 2026
Current end
Nov 16, 2027
Potential end
Nov 16, 2030
with all options
Loading status
Estimated start: Nov 16, 2029
ILLUMINA, INC.
Contract 75F40126P00203
UEI
KMW3CRWNAAF3
Parent Company
ILLUMINA, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 50
Current Obligation
$574,785
Base + Exercised Options
$574,785
Total Ceiling Value
$871,491
Contract Type
FIRM FIXED PRICE
NAICS
ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PSC
LABORATORY EQUIPMENT AND SUPPLIES
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.